Knockdown of DEPDC1B inhibits the development of glioblastoma
Journal: Cancer Cell International
Year: 2020

In summary, DEPDC1B was involved in the development and progression of GBM, which may be a potential therapeutic target and bring a breakthrough in the treatment.